Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,722 | 6,298 | -12,207 | 0 | N/A |
| Depreciation Amortization | 28,643 | 30,316 | 30,924 | 0 | N/A |
| Income taxes - deferred | 644 | -348 | -79 | N/A | N/A |
| Accounts receivable | -3,941 | -14,909 | -12,130 | N/A | N/A |
| Other Working Capital | 15,308 | -13,572 | 2,852 | 0 | N/A |
| Other Operating Activity | 16,423 | 32,928 | 35,827 | 0 | 0 |
| Operating Cash Flow | $71,799 | $40,713 | $45,187 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,579 | -2,342 | -2,561 | 0 | N/A |
| Net Acquisitions | N/A | 430 | N/A | 0 | N/A |
| Purchase Of Investment | -4,093 | -6,000 | -3,500 | N/A | N/A |
| Other Investing Activity | 172 | 0 | -40 | 0 | 0 |
| Investing Cash Flow | $-20,500 | $-7,912 | $-6,101 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,000 | 198,134 | N/A | N/A | N/A |
| Debt Repayment | -59,000 | -199,500 | -5,250 | N/A | N/A |
| Dividend Paid | -19,886 | -9,137 | -7,846 | 0 | N/A |
| Other Financing Activity | 317 | -448 | -160 | 0 | 0 |
| Financing Cash Flow | $-29,569 | $-10,951 | $-13,256 | $0 | $N/A |
| Exchange Rate Effect | 589 | -104 | -160 | 0 | N/A |
| Beginning Cash Position | 64,520 | 42,774 | 17,104 | 0 | N/A |
| End Cash Position | 86,839 | 64,520 | 42,774 | 0 | N/A |
| Net Cash Flow | $22,319 | $21,746 | $25,670 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 71,799 | 40,713 | 45,187 | 0 | N/A |
| Capital Expenditure | -16,579 | -2,342 | -2,561 | N/A | N/A |
| Free Cash Flow | 55,220 | 38,371 | 42,626 | 0 | 0 |